Cargando…

A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time

Influenza and respiratory syncytial virus (RSV) cause acute infections of the respiratory tract. Since the viruses both cause illnesses with similar symptoms, researchers often try to apply knowledge gleaned from study of one virus to the other virus. This can be an effective and efficient strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzàlez-Parra, Gilberto, De Ridder, Filip, Huntjens, Dymphy, Roymans, Dirk, Ispas, Gabriela, Dobrovolny, Hana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805318/ https://www.ncbi.nlm.nih.gov/pubmed/29420667 http://dx.doi.org/10.1371/journal.pone.0192645

Ejemplares similares

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
por: Martinon-Torres, Federico, et al.
Publicado: (2018)

Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model
por: Ispas, Gabriela, et al.
Publicado: (2015)

Assessing Uncertainty in A2 Respiratory Syncytial Virus Viral Dynamics
por: González-Parra, Gilberto, et al.
Publicado: (2015)

Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study
por: Martinón-Torres, Federico, et al.
Publicado: (2020)

Estimation of viral kinetics model parameters in young and aged SARS-CoV-2 infected macaques
por: Rodriguez, Thalia, et al.
Publicado: (2021)

Effect of stochasticity on coinfection dynamics of respiratory viruses
por: Pinky, Lubna, et al.
Publicado: (2019)

Superinfection and cell regeneration can lead to chronic viral coinfections
por: Pinky, Lubna, et al.
Publicado: (2019)

Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results
por: Oey, Abbie, et al.
Publicado: (2023)

Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
por: Bursi, Roberta, et al.
Publicado: (2017)

Investigating Different Mechanisms of Action in Combination Therapy for Influenza
por: Melville, Kelli, et al.
Publicado: (2018)

Summary data of potency and parameter information from semi-mechanistic PKPD modeling of prolactin release following administration of the dopamine D(2) receptor antagonists risperidone, paliperidone and remoxipride in rats
por: Taneja, Amit, et al.
Publicado: (2016)

Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections
por: Rodriguez, Thalia, et al.
Publicado: (2021)

In vitro and in silico analysis of the effects of D (2) receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations
por: de Witte, Wilhelmus E A, et al.
Publicado: (2018)

Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms
por: Dobrovolny, Hana M., et al.
Publicado: (2017)

Mathematical Modeling of Oncolytic Virus Therapy Reveals Role of the Immune Response
por: Guo, Ela, et al.
Publicado: (2023)

Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
por: Jones, Harrison G., et al.
Publicado: (2018)

Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation()()
por: Hawkinson, Dana J., et al.
Publicado: (2016)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients
por: Palmer, John, et al.
Publicado: (2017)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Modeling of prolactin response following dopamine D(2) receptor antagonists in rats: can it be translated to clinical dosing?
por: Taneja, Amit, et al.
Publicado: (2017)

Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Dobrovolny, Hana M.
Publicado: (2020)

Assessing Mathematical Models of Influenza Infections Using Features of the Immune Response
por: Dobrovolny, Hana M., et al.
Publicado: (2013)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants
por: Larios Mora, Alejandro, et al.
Publicado: (2015)

Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
por: Phan, Thuy, et al.
Publicado: (2022)

Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination
por: Assink, M.D.M., et al.
Publicado: (2009)

Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity
por: Dobrovolny, Hana M., et al.
Publicado: (2010)

Mouse model of HDM induced airway inflammation + influenza or RSV. Effects of steroid
por: Lamb, Dave, et al.
Publicado: (2013)

Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013)

Hospital utilization rates for influenza and RSV: a novel approach and critical assessment
por: Johnson, Emily K., et al.
Publicado: (2021)

Competition between RSV and influenza: Limits of modelling inference from surveillance data
por: Waterlow, Naomi R., et al.
Publicado: (2021)

Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead
por: Burki, Talha Khan
Publicado: (2021)

Comparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections
por: Balas, Weronika M., et al.
Publicado: (2023)

Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo
por: Kong, Michele Y.F., et al.
Publicado: (2015)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

Differences in predictions of ODE models of tumor growth: a cautionary example
por: Murphy, Hope, et al.
Publicado: (2016)

Coinfections of the Respiratory Tract: Viral Competition for Resources
por: Pinky, Lubna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hbdhuuq4nococeu38pqfev0k0l